Ono Pharmaceutical
Manufacturing · Japan · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
8-2 Kyutaromachi, Osaka, Osaka, 541-8564...Phone Number
+81 662635670Website
www.ono-pharma.comRevenue
$3.5 BillionStock Symbol
4528Industry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Ono Pharmaceutical
Ono Pharmaceuticals, founded in 1947 and headquartered in Osaka, Japan, is a pharmaceutical manufacturing and research company.Explore more
Ono Pharmaceutical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ono Pharmaceutical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Ono Pharmaceutical had a recent Job posting/layoffs
Check if Ono Pharmaceutical has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Ono Pharmaceutical has new funding data
Check out if Ono Pharmaceutical is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Ono Pharmaceutical
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Ono Pharmaceutical, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Ono Pharmaceutical recently announced quarterly report
Product Launch: Get notified when Ono Pharmaceutical launches new products
Recommended Actions
Find VP level buyers at Ono Pharmaceutical
Find 3 more new buyers
Company Profile Activity
Activity Insights
Ono Pharmaceutical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Ono Pharmaceutical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Ono Pharmaceutical.
Ono Pharmaceutical Tech Stack
A closer look at the technologies used by Ono Pharmaceutical
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Ono Pharmaceutical News & Media
Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical
Scenic enters license and research agreement with Ono Pharmaceutical to utilize Scenic’s Cell-Seq platform for the discovery of novel therapeuticsThe End Brain Cancer Initiative Shares PCNSL Patient Friendly Resource About ONO PHARMA Phase II PROSPECT Study Results
EBCI helps PCNSL patients understand the results from ONO PHARMA's recent phase II PROSPECT study, which tested the safety and efficacy of tirabrutinib. REDMOND, WA, UNITED STATES, December 23, 2025 /EINPresswire.com/ -- ONO PHARMA recently …Deciphera Announces the Opening of a New Office in Zug, Switzerland - Yahoo Finance
OSAKA, Japan & WALTHAM, Mass., November 17, 2025--Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced the opening of a new 733-square-meter office in Zug, Switzerland, to accommodate the company’s growth in Europe and partner markets. The occasion will be commemorated with a ceremony attended by company management, including the CEO of Ono, Gyo Sagara, President and CEO of Deciphera, Ryota Udagawa, and regional government officials,Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
BOSTON & OSAKA, Japan--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Ono Pharmaceutical Co., Ltd. (OTCMKTS: OPHLY) today announced an exclusive collaboration and license agreement for the development and commercialization of Vertex’s povetacicept in Japan and South Korea. Povetacicept is a recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines with best-in-class potential b
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ono Pharmaceutical
Sign Up For FreeTo access detailed company insights
Ono Pharmaceuticals, founded in 1947 and headquartered in Osaka, Japan, is a pharmaceutical manufacturing and research company.... Read More
